Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Tianda Pharmaceuticals Ltd. ( (HK:0455) ).
Tianda Pharmaceuticals Limited has scheduled its 2026 annual general meeting for 12 June 2026 in Central, Hong Kong, setting 9 June 2026 as the record date for shareholders entitled to attend, speak and vote. To facilitate this, the company will close its register of members from 9 to 12 June 2026, during which no share transfers will be processed, and shareholders must ensure relevant transfer documents are lodged by 8 June 2026 to participate.
The announcement provides procedural clarity for investors and underscores the company’s adherence to formal corporate governance practices typical of Hong Kong–listed firms. By clearly outlining key deadlines and logistics around the AGM, Tianda Pharmaceuticals offers transparency to shareholders and helps ensure orderly participation and voting, which is important for investor confidence and regulatory compliance.
More about Tianda Pharmaceuticals Ltd.
Tianda Pharmaceuticals Limited is a Hong Kong-listed pharmaceutical company engaged in the development and commercialization of healthcare products. The company operates under a board comprising executive, non-executive and independent non-executive directors, reflecting a typical governance structure for a mid-sized listed healthcare firm in the region.
Average Trading Volume: 96,100
Technical Sentiment Signal: Sell
Current Market Cap: HK$208.6M
For a thorough assessment of 0455 stock, go to TipRanks’ Stock Analysis page.